--- schema_version: "secwatch.filing_event.v1" accession: "0001193125-24-100968" form_type: "8-K" ticker: "MPT" cik: "0001287865" company_name: "MEDICAL PROPERTIES TRUST INC" filed_at: "2024-04-18T23:59:59+00:00" generated_at: "2026-06-03T18:17:46.187244+00:00" event_type: "other_material" sentiment: "positive" materiality_score: 0.85 calibrated_materiality_score: 0.85 confidence: "high" source: SEC EDGAR --- # MPT sells majority stake in five Utah hospitals for ~$1.1B cash; repays Australian term loan ## Summary - Sold interests in five Utah hospitals to JV with Blue Owl RE Nucleus; retained ~25% stake. - Fund paid $886M for 75% interest; JV secured $190M non-recourse financing; total cash ~$1.1B. - Proceeds used to fully repay ~$300M Australian term loan due 2024 and reduce revolver borrowings. - Credit facility amendments: revolver reduced from $1.8B to $1.4B; secured leverage cap lowered to 25%. - Management: now confident of exceeding initial $2B liquidity target for 2024 given recent valuations. ## SEC filing metadata - accession: 0001193125-24-100968 - form_type: 8-K - ticker: MPT - cik: 0001287865 - company_name: MEDICAL PROPERTIES TRUST INC - filed_at: 2024-04-18T23:59:59+00:00 - event_type: other_material - sentiment: positive - materiality_score: 0.85 - calibrated_materiality_score: 0.85 - confidence: high - sec_items: 1.01, 2.01, 1.02, 7.01, 9.01 - EDGAR index: https://www.sec.gov/Archives/edgar/data/1287865/000119312524100968/0001193125-24-100968-index.htm - EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1287865/000119312524100968/d804873d8k.htm ## Machine-readable alternates - HTML: https://secwatch.observer/filing/0001193125-24-100968 - JSON: https://secwatch.observer/filing/0001193125-24-100968.json - Plain text: https://secwatch.observer/filing/0001193125-24-100968.txt ## Key facts - M&A Transactions MEDICAL PROPERTIES TRUST INC completed a disposition involving Blue Owl RE Nucleus Holdco LLC for 886 million (closed 2024-04-12). - Action: disposition - Counterparty: Blue Owl RE Nucleus Holdco LLC - Consideration: 886 million - Closing: 2024-04-12 source text: approximate 25% interest in the Venture with an aggregate agreed valuation of approximately $1.2 billion, and the Fund purchased an approximate 75% interest in the Venture for $886 million. There are no material relationships, other than in respect of the Venture, between the Company, the Operating Partnership, and the Fund or any of their affiliates. Simultaneous evidence_url: https://www.sec.gov/Archives/edgar/data/1287865/000119312524100968/0001193125-24-100968-index.htm - Material Agreements MEDICAL PROPERTIES TRUST INC amended Australia Facility Amendment with Evolution Trustees Limited, as trustee for MPT Australia Realty Trust, Bank of America, N.A., as administrative agent, and the lenders party thereto (effective 2024-04-12). - Action: amendment - Agreement: credit facility - Counterparty: Evolution Trustees Limited, as trustee for MPT Australia Realty Trust, Bank of America, N.A., as administrative agent, and the lenders party thereto - Effective: 2024-04-12 source text: and (ii) the Fifth Amendment (the “Australia Facility Amendment”) to the Syndicated Facility Agreement, dated as of May 23, 2019, by and among the Company, the Borrower, Evolution Trustees Limited, as trustee for MPT Australia Realty Trust, Bank of America, N.A. as administrative agent and the lenders party thereto (the “Australia Facility”). evidence_url: https://www.sec.gov/Archives/edgar/data/1287865/000119312524100968/0001193125-24-100968-index.htm - Material Agreements MEDICAL PROPERTIES TRUST INC amended Credit Facility Amendment with JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto (effective 2024-04-12). - Action: amendment - Agreement: credit facility - Counterparty: JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto - Effective: 2024-04-12 source text: On April 12, 2024, Medical Properties Trust, Inc., a Maryland corporation (the “Company”), and MPT Operating Partnership, L.P., a Delaware limited partnership and the Company’s operating partnership (the “Operating Partnership” or the “Borrower”), entered into (i) Amendment No. 1 (the “Credit Facility Amendment”) to the Second Amended and Restated Revolving Credit and Term Loan Agreement, dated as of June 29, 2022, by and among the Company, the Borrower, JPMorgan Chase Bank, N.A., as administrative agent and the lenders party thereto (the “Credit Facility”), evidence_url: https://www.sec.gov/Archives/edgar/data/1287865/000119312524100968/0001193125-24-100968-index.htm - Material Agreements MEDICAL PROPERTIES TRUST INC entered into a asset purchase with a newly formed joint venture valued at approximately $1.1 billion (effective 2024-04-12). - Action: entry - Agreement: asset purchase - Counterparty: a newly formed joint venture - Value: approximately $1.1 billion - Effective: 2024-04-12 source text: Also on April 12, 2024, the Company sold its interest in five Utah hospitals to a newly formed joint venture, generating immediate cash proceeds of approximately $1.1 billion evidence_url: https://www.sec.gov/Archives/edgar/data/1287865/000119312524100968/0001193125-24-100968-index.htm This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.